Ivermectin: South Africa Bans ‘Miracle’ COVID-19 Treatment as “Unsafe”

The import into South Africa of ivermectin, a drug that has made international headlines recently as a so-called “miracle cure” for Covid-19, has been declared illegal by the South African Health Products Regulatory Authority (Sahpra).

Ivermectin, which has been used for decades to treat livestock and people infested with parasitic worms, was hailed as a revolutionary drug in the 1980s and works by paralysing and killing parasites.

In a statement, Sahpra chief executive Dr Boitumelo Semete-Makokotlela said:

“Our stance is unambiguous. This drug is not approved by Sahpra and any attempt to import it into the country will be dealt with by Sahpra’s regulatory compliance unit in conjunction with law enforcement agencies such as the SAPS and the SIU.”

Semete-Makokotlela said:

“If any member of the public is aware of such transgressions, please contact Deon Poovan, senior manager of Sahpra’s Inspectorate and Regulatory Compliance on [email protected]

“At present, there is no confirmatory clinical evidence available for the use of ivermectin in the management of Covd-19 infections,” said Semete-Makokotlela.

“In terms of safety and efficacy, there is no evidence to support the use of ivermectin and we do not have any clinical trial evidence to justify its use.

“Sahpra is focused on quality, safety and efficacy and its ultimate goal is to protect the health and well-being of all those who live in South Africa. The use of such a drug could potentially lead to harmful effects or even death,” said Semete-Makokotlela.

Reached for comment, provincial head of health Dr Keith Cloete said:

“We will be guided by the expert advice of the national Essential Medicine List (EML) committee and the ministerial advisory committee for Covid-19, who will pronounce on this matter.”

Provincial health department spokesperson Mark van der Heever said:

“We only use medication and drugs which are approved by Sahpra.”

During a hearing before the US senate homeland security and governmental affairs committee last week, Dr Pierre Kory, a pulmonary and critical care specialist at Aurora St Luke’s Medical Center in Milwaukee, described ivermectin as a “wonder drug” with immensely powerful antiviral and anti-inflammatory agents.

Kory said:

“Ivermectin is highly safe, widely available, and low cost. Its discovery was awarded the Nobel Prize in medicine, and is already included on the WHO’s World’s List of Essential Medicines. Ivermectin is effectively a miracle drug against Covid-19.”

The hearing went viral on social media with one clip receiving more than one million views on YouTube, and a number of people around the world including in South Africa where the second wave of Covid-19 appears to be worse than the first time around, have since called for governments and regulators allow the drug for use against Covid-19.

The WHO and health authorities worldwide have urged people to be wary of so-called Covid-19 miracle cures.


Note to readers: please click the share buttons above or below. Forward this article to your email lists. Crosspost on your blog site, internet forums. etc.

Articles by: Mwangi Githahu

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]